Compare Stocks

Enter up to five stock symbols separated by a comma or space (e.x BAC,WFC,JPM,LON:BARC).
 

 AmgenGilead SciencesBiogenSeattle GeneticsNOVOZYMES A/S/S
SymbolNASDAQ:AMGNNASDAQ:GILDNASDAQ:BIIBNASDAQ:SGENOTCMKTS:NVZMY
Price Information
Current Price$195.47$66.52$236.63$70.63$43.23
52 Week RangeBuyBuyHoldBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyHoldBuyBuy
Consensus Price Target$216.9375$82.90$270.00$85.2727N/A
% Upside from Price Target10.98% upside24.62% upside14.10% upside20.73% upsideN/A
Trade Information
Market Cap$117.45 billion$86.22 billion$43.52 billion$11.46 billion$13.15 billion
Beta1.111.11.011.970.76
Average Volume2,807,1585,714,0331,182,310584,87622,548
Sales & Book Value
Annual Revenue$23.75 billion$22.13 billion$13.45 billion$654.70 million$2.28 billion
Price / Sales4.943.813.2417.455.63
Cashflow$18.0489 per share$7.1604 per share$31.8479 per shareN/A$1.6801 per share
Price / Cash10.839.297.43N/A25.73
Book Value$19.62 per share$16.65 per share$64.68 per share$7.95 per share$6.10 per share
Price / Book9.964.003.668.887.09
Profitability
Net Income$8.39 billion$5.46 billion$4.43 billion$-222,690,000.00$511 million
EPS$14.40$6.15$26.20($1.65)$1.75
Trailing P/E Ratio13.5710.829.03N/A24.70
Forward P/E Ratio12.689.757.35N/A24.70
P/E Growth$2.29$3.23$0.87N/A$2.10
Net Margins33.78%26.64%37.62%-36.94%22.31%
Return on Equity (ROE)76.17%37.12%44.89%-17.16%28.26%
Return on Assets (ROA)14.36%13.06%23.23%-14.39%15.95%
Dividend
Annual Payout$5.80$2.52N/AN/A$0.50
Dividend Yield2.97%3.79%N/AN/A1.16%
Three-Year Dividend Growth18.70%20.90%N/AN/AN/A
Payout Ratio40.28%40.98%N/AN/A28.57%
Years of Consecutive Dividend Growth8 Years3 YearsN/AN/AN/A
Debt
Debt-to-Equity Ratio2.58%1.13%0.49%N/A0.05%
Current Ratio2.89%3.76%2.46%3.03%1.22%
Quick Ratio2.60%3.67%2.22%2.70%0.71%
Ownership Information
Institutional Ownership Percentage76.28%79.89%86.55%99.14%0.18%
Insider Ownership Percentage0.25%0.20%0.39%33.80%N/A
Miscellaneous
Employees21,50011,0007,8001,3026,427
Shares Outstanding599.70 million1.27 billion184.45 million161.72 million297.00 million
Next Earnings Date10/29/2019 (Estimated)10/24/2019 (Estimated)10/22/2019 (Estimated)10/24/2019 (Estimated)10/23/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableNot Optionable
 AmgenGilead SciencesBiogenSeattle GeneticsNOVOZYMES A/S/S

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel